• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

    Novartis Invests in Credence MedSystems

    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement

    Almac Expands Global Biologics Testing Services

    GRAM Makes Major Investment in Additional Advanced Equipment
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement

    GRAM Makes Major Investment in Additional Advanced Equipment

    Aphena’s $21M Cookeville Expansion Nears Completion

    PromoCell Receives EXCiPACT Certification

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Novartis Invests in Credence MedSystems

    Aphena’s $21M Cookeville Expansion Nears Completion

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

    Almac Expands Global Biologics Testing Services

    The State of Clinical Trial Technology

    Adare Pharma Solutions Opens New Small-Scale Lab

    The Future of Clinical Trials Series: Part II
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Alcami

    Emergent BioSolutions

    Cytovance Biologics

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Baxter BioPharma Solutions

    Emergent BioSolutions

    Adare Pharma Solutions

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    BMS Dublin Site Wins ISPE ‘Facility of the Year’ Award

    Jacobs’ designed Dublin-Cruiserath campus, specializing in the production of biologics and immuno-oncology treatments, recognized for Project Execution.

    BMS Dublin Site Wins ISPE ‘Facility of the Year’ Award
    BMS engaged Jacobs to reimagine its existing API plant in Dublin, Ireland, to enable large-scale production of its immuno-oncology medicines.
    Contract Pharma Staff06.24.20
    Bristol Myers Squibb’s Cruiserath Biologics site based in Dublin, Ireland, has won the Project Execution category at the International Society for Pharmaceutical Engineering (ISPE) 2020 Facility of the Year Awards (FOYA). The award recognizes innovation in facilities serving the regulated healthcare industry. The factory, optimized for rapid product changeover and future use as a multi-product facility, will support Bristol Myers Squibb (BMS) in meeting growing global demand for its medicines. Jacobs provided architecture, engineering, construction management and turnover services for the world class biopharmaceutical manufacturing facility.
     
    In 2015, biopharmaceutical manufacturer BMS engaged Jacobs to reimagine its existing active pharmaceutical ingredients (API) plant in Dublin, Ireland, to enable large-scale production of its vital immuno-oncology medicines.
     
    Jacobs was tasked with creating a facility of the future for the $1 billion Multi-Product Cell Culture (MPCC) facility. At the time, the project represented the largest pharmaceutical project being undertaken in Europe, with more than 2,200 people on site at peak. The project’s fast-tracked 26-month delivery commanded collaboration from Jacobs’ global network of expertise across Ireland, the U.S. and India, working around the clock to meet the ambitious schedule.
     
    The complexity, scale and speed of execution required game-changing project delivery. A detailed and robust project execution plan was developed to address challenges, monitor progress and ensure project success. The facility was delivered within budget, applying state‐of‐the‐art project delivery techniques and tools, and achieving an impressive safety record during the 6.5 million hours worked. The facility was also awarded LEED Silver certification for its sustainability performance in respect of design, construction and operation. 
     
    “With growing demands for its immuno-oncology medicine, Bristol Myers Squibb needed to build a facility for the future,” said Koti Vadlamudi, senior vice president, advanced facilities, Jacobs. “The project is a huge success for Jacobs, Bristol Myers Squibb, and ultimately the many patients that rely on these medicines produced in the Dublin campus.”
     
    The facility met the design intent to be a flexible, multi-product manufacturing operation able to produce biopharmaceuticals for human therapeutic use. The project repurposed an existing site to design and construct a new manufacturing facility, global laboratory, offices, cafeteria, utility and warehouse buildings as one functional campus. The facility is now in commercial operation, having recently received regulatory approval from both the FDA and the European Medicines Authority.
     
    Commenting on the award, Noel Heaney, Cruiserath biologics general manager and executive director, EU biologics, BMS, said, “Cruiserath’s campus represents the largest ever capital investment for the company and is the first Bristol Myers Squibb biologics manufacturing facility in Europe. We set out with a vision to build a world class Biopharma Campus and state of the art facility, and to receive this highly coveted external and industry recognition indeed signifies we are well on our way.”

    Related Breaking News

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
      Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

      Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

      Lilly expands BLAZE-4 trial to evaluate bamlanivimab with VIR-7831, two neutralizing antibodies that bind to different epitopes of the SARS-CoV-2 spike protein.
      Kristin Brooks 01.27.21

    • Breaking News | Collaborations & Alliances | Industry News | Injectables
      Novartis Invests in Credence MedSystems

      Novartis Invests in Credence MedSystems

      Supporting ramp-up of manufacturing capacity for innovative injectable drug delivery systems.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Bio News | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Parenterals
      Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement

      Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement

      Ajinomoto will support fill finish for investigational COVID-19 therapeutic, lenzilumab, nearing completion of phase 3 study.
      Tim Wright, Editor, Contract Pharma 01.27.21


    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News | Laboratory Testing
      Almac Expands Global Biologics Testing Services

      Almac Expands Global Biologics Testing Services

      Investment in mass spectrometry support aims to accelerate biologics development and approval.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Aseptic Processing | Breaking News | Collaborations & Alliances | Facilities | Industry News | Parenterals
      GRAM Makes Major Investment in Additional Advanced Equipment

      GRAM Makes Major Investment in Additional Advanced Equipment

      Bausch+Ströbel vial filler with SKAN Isolator technology, and VarioSys syringe and vial filler set to arrive in early 2022.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Breaking News | Formulation Development | Industry News | Methods Development
      Adare Pharma Solutions Opens New Small-Scale Lab

      Adare Pharma Solutions Opens New Small-Scale Lab

      Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.
      Kristin Brooks 01.26.21


    • Breaking News | Industry News
      Stevanato Group Launches After-sales Service Offering

      Stevanato Group Launches After-sales Service Offering

      Aims to deliver a more customized experience for optimal machine maintenance, performance and utilization.
      Kristin Brooks 01.26.21

    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      X-Chem Acquires IntelliSyn and AviSyn

      X-Chem Acquires IntelliSyn and AviSyn

      Acquisitions allow the company to offer services for screening, hit validation and lead optimization on existing and new markets.
      Kristin Brooks 01.26.21

    • Breaking News | Capsules | Cold Chain Management | Fill/Finish | Industry News | Solid Dosage/Semi-solids
      Aphena’s $21M Cookeville Expansion Nears Completion

      Aphena’s $21M Cookeville Expansion Nears Completion

      Bottle packaging capacity has been expanded with the installation of 10 high-speed bottling lines to start.
      Kristin Brooks 01.26.21


    • Breaking News | Collaborations & Alliances
      BioMed X, Janssen Enter Oral Drug Delivery Alliance

      BioMed X, Janssen Enter Oral Drug Delivery Alliance

      Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.
      Charles Sternberg, Assistant Editor 01.26.21

    • Breaking News | Clinical Trials | Industry News
      Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

      Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

      Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.
      Kristin Brooks 01.26.21

    • Breaking News
      500+ Sites Join Inato’s Industry Marketplace

      500+ Sites Join Inato’s Industry Marketplace

      Platform aims to make clinical research more inclusive and efficient.
      Charles Sternberg, Assistant Editor 01.26.21


    • Breaking News | Clinical Trials | Drug Development | Industry News | Laboratory Testing
      Caprion-HistoGeneX Rebrands as CellCarta

      Caprion-HistoGeneX Rebrands as CellCarta

      Recently expanded its scientific capabilities and geographic presence with the acquisitions of Clinical Logistics Inc. and Mosaic Laboratories.
      Kristin Brooks 01.26.21

    • Breaking News | cGMP Manufacture | Excipients | Industry News
      PromoCell Receives EXCiPACT Certification

      PromoCell Receives EXCiPACT Certification

      Manufactures pharmaceutical excipients to GMP standards for tailor-made cell culture media and reagents that fulfill specific regulatory requirements.
      Kristin Brooks 01.26.21

    • Breaking News | Facilities | Industry News | Injectables | Parenterals
      Civica to Build an Essential Medicines Manufacturing Facility in Virginia

      Civica to Build an Essential Medicines Manufacturing Facility in Virginia

      Will produce sterile injectable meds used in hospitals for COVID-19 patient care.
      Tim Wright, Editor, Contract Pharma 01.25.21

    Trending
    • Integrated Continuous Manufacturing ICM
    • Humanigen, Emergent Enter Covid-19 Partnership
    • 500+ Sites Join Inato’s Industry Marketplace
    • Samsung Bioepis Opens New Headquarters
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    • Novartis Invests in Credence MedSystems
    • Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    • Almac Expands Global Biologics Testing Services
    • GRAM Makes Major Investment in Additional Advanced Equipment
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

      View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PepsiCo and Beyond Meat Partner to Develop Plant-Based Protein
    New Study on Sage Extract Formula Suggests Memory Enhancement
    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    Coatings World

    Latest Breaking News From Coatings World

    Mississippi Lime Company Announces New Director of Safety
    IFS Coatings Launches IFS Puroplaz PE20 Texture
    Keyland Polymer UV Powder, LLC Launches UVMax Defender
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spectrum Solutions Collaborates with UCLA School of Dentistry
    Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization
    Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    Novartis Invests in Credence MedSystems
    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty to Shut Down Manufacturing Site in Cologne, Germany
    L’Occitane Files for Bankruptcy in U.S.
    Bésame Cosmetics Collaborates with Disney on Mary Poppins Collection
    Happi

    Latest Breaking News From Happi

    HI Beach Installs Reef-friendly Sunscreen Dispenser
    RB Partners with Airbnb
    L'Occitane US Files for Bankruptcy
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Georgia-Pacific Acquires 3rd HP PageWide Corrugated Press to Expand Hummingbird Digital Printing
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex acquires MDV Group
    Fix-A-Form eyes global expansion
    McCracken Label installs Fujifilm water-wash plate system
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Nice-Pak Receives EPA Approval for Disinfecting Wipes
    Rockline to Invest $18 Million in Arkansas
    Essity’s Sales Negatively Impacted by Covid-19 Pandemic
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ChoiceSpine's Tiger Shark Cervical Spacer Earns Additional 510(k)
    FDA Green Lights Inspired Spine's Trident SI Joint Screw System
    FDA Clears Method to Extract Bone Measurements From X-Rays
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Osram Sees Jump in Profits in Preliminary 2020 Report
    LG Display Reports 4Q 2020 Results
    Xerox Releases 4Q, Full Year Results

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login